AMSTERDAM — Google is developing digital platforms, forming partnerships with agencies and healthcare providers, and promoting disease prevention, with generative AI models a key part of […]

In March of 2024, four women in Tennessee and three in New York City fell ill after receiving botulinum neurotoxin (BoNT) injections in nonmedical settings, and […]

AMSTERDAM — Digital telemedicine has become a well-established part of depression management. Now, digital therapies like virtual reality games and brain stimulation headsets are making their […]

An accelerated schedule of intermittent theta burst transcranial magnetic stimulation (aiTBS) completed in less than a week is effective for treatment-resistant bipolar depression, the results of […]

HELSINKI, Finland — A new gene for early-onset Parkinson’s disease (PD) has been identified, a discovery that experts believe will have important clinical implications in the […]

An analysis based on a massive database of US electronic health records (EHRs) adds to evidence favoring the safety of glucagon-like peptide 1 (GLP-1) medications, finding […]

July 16, 2024 — Neurologic symptoms of long COVID are vast, common, hard to treat, disabling, and can mimic dozens of other syndromes, with some symptoms […]